Specialty Generics Market, Global Outlook and Forecast 2022-2028

February 2022 | 60 pages | ID: SFF19AFDB268EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Specialty Generics in Global, including the following market information:

Global Specialty Generics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Specialty Generics market was valued at 78730 million in 2021 and is projected to reach US$ 214680 million by 2028, at a CAGR of 15.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injectables Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Specialty Generics include Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals and Apotex Corp. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Specialty Generics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Specialty Generics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Specialty Generics Market Segment Percentages, by Type, 2021 (%)

• Injectables
• Oral
• Others

Global Specialty Generics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Specialty Generics Market Segment Percentages, by Application, 2021 (%)

• Retail Pharmacies
• Specialty Pharmacies
• Hospital Pharmacies

Global Specialty Generics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Specialty Generics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Specialty Generics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Specialty Generics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva Pharmaceuticals Industries
• Akorn, Inc.
• Mylan N.V.
• Mallinckrodt
• Sandoz International GmbH
• Pfizer, Inc.
• Sun Pharmaceutical Industries Ltd.
• Valeant Pharmaceuticals
• Apotex Corp.
• Endo International plc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Specialty Generics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Specialty Generics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SPECIALTY GENERICS OVERALL MARKET SIZE

2.1 Global Specialty Generics Market Size: 2021 VS 2028
2.2 Global Specialty Generics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Specialty Generics Players in Global Market
3.2 Top Global Specialty Generics Companies Ranked by Revenue
3.3 Global Specialty Generics Revenue by Companies
3.4 Top 3 and Top 5 Specialty Generics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Specialty Generics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Specialty Generics Players in Global Market
  3.6.1 List of Global Tier 1 Specialty Generics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Specialty Generics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Specialty Generics Market Size Markets, 2021 & 2028
  4.1.2 Injectables
  4.1.3 Oral
  4.1.4 Others
4.2 By Type - Global Specialty Generics Revenue & Forecasts
  4.2.1 By Type - Global Specialty Generics Revenue, 2017-2022
  4.2.2 By Type - Global Specialty Generics Revenue, 2023-2028
  4.2.3 By Type - Global Specialty Generics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Specialty Generics Market Size, 2021 & 2028
  5.1.2 Retail Pharmacies
  5.1.3 Specialty Pharmacies
  5.1.4 Hospital Pharmacies
5.2 By Application - Global Specialty Generics Revenue & Forecasts
  5.2.1 By Application - Global Specialty Generics Revenue, 2017-2022
  5.2.2 By Application - Global Specialty Generics Revenue, 2023-2028
  5.2.3 By Application - Global Specialty Generics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Specialty Generics Market Size, 2021 & 2028
6.2 By Region - Global Specialty Generics Revenue & Forecasts
  6.2.1 By Region - Global Specialty Generics Revenue, 2017-2022
  6.2.2 By Region - Global Specialty Generics Revenue, 2023-2028
  6.2.3 By Region - Global Specialty Generics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Specialty Generics Revenue, 2017-2028
  6.3.2 US Specialty Generics Market Size, 2017-2028
  6.3.3 Canada Specialty Generics Market Size, 2017-2028
  6.3.4 Mexico Specialty Generics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Specialty Generics Revenue, 2017-2028
  6.4.2 Germany Specialty Generics Market Size, 2017-2028
  6.4.3 France Specialty Generics Market Size, 2017-2028
  6.4.4 U.K. Specialty Generics Market Size, 2017-2028
  6.4.5 Italy Specialty Generics Market Size, 2017-2028
  6.4.6 Russia Specialty Generics Market Size, 2017-2028
  6.4.7 Nordic Countries Specialty Generics Market Size, 2017-2028
  6.4.8 Benelux Specialty Generics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Specialty Generics Revenue, 2017-2028
  6.5.2 China Specialty Generics Market Size, 2017-2028
  6.5.3 Japan Specialty Generics Market Size, 2017-2028
  6.5.4 South Korea Specialty Generics Market Size, 2017-2028
  6.5.5 Southeast Asia Specialty Generics Market Size, 2017-2028
  6.5.6 India Specialty Generics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Specialty Generics Revenue, 2017-2028
  6.6.2 Brazil Specialty Generics Market Size, 2017-2028
  6.6.3 Argentina Specialty Generics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Specialty Generics Revenue, 2017-2028
  6.7.2 Turkey Specialty Generics Market Size, 2017-2028
  6.7.3 Israel Specialty Generics Market Size, 2017-2028
  6.7.4 Saudi Arabia Specialty Generics Market Size, 2017-2028
  6.7.5 UAE Specialty Generics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Teva Pharmaceuticals Industries
  7.1.1 Teva Pharmaceuticals Industries Corporate Summary
  7.1.2 Teva Pharmaceuticals Industries Business Overview
  7.1.3 Teva Pharmaceuticals Industries Specialty Generics Major Product Offerings
  7.1.4 Teva Pharmaceuticals Industries Specialty Generics Revenue in Global Market (2017-2022)
  7.1.5 Teva Pharmaceuticals Industries Key News
7.2 Akorn, Inc.
  7.2.1 Akorn, Inc. Corporate Summary
  7.2.2 Akorn, Inc. Business Overview
  7.2.3 Akorn, Inc. Specialty Generics Major Product Offerings
  7.2.4 Akorn, Inc. Specialty Generics Revenue in Global Market (2017-2022)
  7.2.5 Akorn, Inc. Key News
7.3 Mylan N.V.
  7.3.1 Mylan N.V. Corporate Summary
  7.3.2 Mylan N.V. Business Overview
  7.3.3 Mylan N.V. Specialty Generics Major Product Offerings
  7.3.4 Mylan N.V. Specialty Generics Revenue in Global Market (2017-2022)
  7.3.5 Mylan N.V. Key News
7.4 Mallinckrodt
  7.4.1 Mallinckrodt Corporate Summary
  7.4.2 Mallinckrodt Business Overview
  7.4.3 Mallinckrodt Specialty Generics Major Product Offerings
  7.4.4 Mallinckrodt Specialty Generics Revenue in Global Market (2017-2022)
  7.4.5 Mallinckrodt Key News
7.5 Sandoz International GmbH
  7.5.1 Sandoz International GmbH Corporate Summary
  7.5.2 Sandoz International GmbH Business Overview
  7.5.3 Sandoz International GmbH Specialty Generics Major Product Offerings
  7.5.4 Sandoz International GmbH Specialty Generics Revenue in Global Market (2017-2022)
  7.5.5 Sandoz International GmbH Key News
7.6 Pfizer, Inc.
  7.6.1 Pfizer, Inc. Corporate Summary
  7.6.2 Pfizer, Inc. Business Overview
  7.6.3 Pfizer, Inc. Specialty Generics Major Product Offerings
  7.6.4 Pfizer, Inc. Specialty Generics Revenue in Global Market (2017-2022)
  7.6.5 Pfizer, Inc. Key News
7.7 Sun Pharmaceutical Industries Ltd.
  7.7.1 Sun Pharmaceutical Industries Ltd. Corporate Summary
  7.7.2 Sun Pharmaceutical Industries Ltd. Business Overview
  7.7.3 Sun Pharmaceutical Industries Ltd. Specialty Generics Major Product Offerings
  7.7.4 Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue in Global Market (2017-2022)
  7.7.5 Sun Pharmaceutical Industries Ltd. Key News
7.8 Valeant Pharmaceuticals
  7.8.1 Valeant Pharmaceuticals Corporate Summary
  7.8.2 Valeant Pharmaceuticals Business Overview
  7.8.3 Valeant Pharmaceuticals Specialty Generics Major Product Offerings
  7.8.4 Valeant Pharmaceuticals Specialty Generics Revenue in Global Market (2017-2022)
  7.8.5 Valeant Pharmaceuticals Key News
7.9 Apotex Corp.
  7.9.1 Apotex Corp. Corporate Summary
  7.9.2 Apotex Corp. Business Overview
  7.9.3 Apotex Corp. Specialty Generics Major Product Offerings
  7.9.4 Apotex Corp. Specialty Generics Revenue in Global Market (2017-2022)
  7.9.5 Apotex Corp. Key News
7.10 Endo International plc.
  7.10.1 Endo International plc. Corporate Summary
  7.10.2 Endo International plc. Business Overview
  7.10.3 Endo International plc. Specialty Generics Major Product Offerings
  7.10.4 Endo International plc. Specialty Generics Revenue in Global Market (2017-2022)
  7.10.5 Endo International plc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Specialty Generics Market Opportunities & Trends in Global Market
Table 2. Specialty Generics Market Drivers in Global Market
Table 3. Specialty Generics Market Restraints in Global Market
Table 4. Key Players of Specialty Generics in Global Market
Table 5. Top Specialty Generics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Specialty Generics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Specialty Generics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Specialty Generics Product Type
Table 9. List of Global Tier 1 Specialty Generics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Specialty Generics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Specialty Generics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Specialty Generics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Specialty Generics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Specialty Generics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Specialty Generics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Specialty Generics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Specialty Generics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Specialty Generics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Specialty Generics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Specialty Generics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Specialty Generics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Specialty Generics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Specialty Generics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Specialty Generics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Specialty Generics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Specialty Generics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Specialty Generics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Specialty Generics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Specialty Generics Revenue, (US$, Mn), 2023-2028
Table 30. Teva Pharmaceuticals Industries Corporate Summary
Table 31. Teva Pharmaceuticals Industries Specialty Generics Product Offerings
Table 32. Teva Pharmaceuticals Industries Specialty Generics Revenue (US$, Mn), (2017-2022)
Table 33. Akorn, Inc. Corporate Summary
Table 34. Akorn, Inc. Specialty Generics Product Offerings
Table 35. Akorn, Inc. Specialty Generics Revenue (US$, Mn), (2017-2022)
Table 36. Mylan N.V. Corporate Summary
Table 37. Mylan N.V. Specialty Generics Product Offerings
Table 38. Mylan N.V. Specialty Generics Revenue (US$, Mn), (2017-2022)
Table 39. Mallinckrodt Corporate Summary
Table 40. Mallinckrodt Specialty Generics Product Offerings
Table 41. Mallinckrodt Specialty Generics Revenue (US$, Mn), (2017-2022)
Table 42. Sandoz International GmbH Corporate Summary
Table 43. Sandoz International GmbH Specialty Generics Product Offerings
Table 44. Sandoz International GmbH Specialty Generics Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer, Inc. Corporate Summary
Table 46. Pfizer, Inc. Specialty Generics Product Offerings
Table 47. Pfizer, Inc. Specialty Generics Revenue (US$, Mn), (2017-2022)
Table 48. Sun Pharmaceutical Industries Ltd. Corporate Summary
Table 49. Sun Pharmaceutical Industries Ltd. Specialty Generics Product Offerings
Table 50. Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue (US$, Mn), (2017-2022)
Table 51. Valeant Pharmaceuticals Corporate Summary
Table 52. Valeant Pharmaceuticals Specialty Generics Product Offerings
Table 53. Valeant Pharmaceuticals Specialty Generics Revenue (US$, Mn), (2017-2022)
Table 54. Apotex Corp. Corporate Summary
Table 55. Apotex Corp. Specialty Generics Product Offerings
Table 56. Apotex Corp. Specialty Generics Revenue (US$, Mn), (2017-2022)
Table 57. Endo International plc. Corporate Summary
Table 58. Endo International plc. Specialty Generics Product Offerings
Table 59. Endo International plc. Specialty Generics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Specialty Generics Segment by Type in 2021
Figure 2. Specialty Generics Segment by Application in 2021
Figure 3. Global Specialty Generics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Specialty Generics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Specialty Generics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Specialty Generics Revenue in 2021
Figure 8. By Type - Global Specialty Generics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Specialty Generics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Specialty Generics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Specialty Generics Revenue Market Share, 2017-2028
Figure 12. US Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Specialty Generics Revenue Market Share, 2017-2028
Figure 16. Germany Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 17. France Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Specialty Generics Revenue Market Share, 2017-2028
Figure 24. China Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 28. India Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Specialty Generics Revenue Market Share, 2017-2028
Figure 30. Brazil Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Specialty Generics Revenue Market Share, 2017-2028
Figure 33. Turkey Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Specialty Generics Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Pharmaceuticals Industries Specialty Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Akorn, Inc. Specialty Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan N.V. Specialty Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mallinckrodt Specialty Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sandoz International GmbH Specialty Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer, Inc. Specialty Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Valeant Pharmaceuticals Specialty Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Apotex Corp. Specialty Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Endo International plc. Specialty Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)